Anonymous
Guest
Anonymous
Guest
Another launch about to start and the plans are big. So big, that we can't even properly launch them with teams of 4-5 people per territory? The PC team is needed to help this product along? Has no one ever heard of diminishing returns?
Has the company learned nothing since launching Brillinta? What has the saturation bombing of customers accomplished? It and Farxiga aren't blockbusters. Maybe a few hundred million dollars each if we can keep the investigators out of jail. Neither of these alone nor both together would pull anything but the smallest pharma concern out the doldrums much less the serious trouble facing AZ.
When the pressure to meet unrealistic expectations collides with the reality of a market full of competing products, we'll be faced with the prospects of heads rolling. To avoid it being our own, corners will be cut and rules will be broken. Lies will be told. Backs will be stabbed. All in a game of "Pretend we can keep being Big Pharma" just a bit longer, so leadership can collect their performance bonuses while failing to lead at all.
What a pity.
Has the company learned nothing since launching Brillinta? What has the saturation bombing of customers accomplished? It and Farxiga aren't blockbusters. Maybe a few hundred million dollars each if we can keep the investigators out of jail. Neither of these alone nor both together would pull anything but the smallest pharma concern out the doldrums much less the serious trouble facing AZ.
When the pressure to meet unrealistic expectations collides with the reality of a market full of competing products, we'll be faced with the prospects of heads rolling. To avoid it being our own, corners will be cut and rules will be broken. Lies will be told. Backs will be stabbed. All in a game of "Pretend we can keep being Big Pharma" just a bit longer, so leadership can collect their performance bonuses while failing to lead at all.
What a pity.